Advertisement

Topics

Cara Therapeutics, Inc. Company Profile

01:16 EDT 30th May 2017 | BioPortfolio


News Articles [2079 Associated News Articles listed on BioPortfolio]

Cara Therapeutics (CARA) Presents At 16th Annual Needham Healthcare Conference - Slideshow

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q4 2016 Results - Earnings Call Transcript

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q1 2017 Results - Earnings Call Transcript

Cara Therapeutics (CARA) Updates on CR845-CLIN2101 - Slideshow

Cara Therapeutics (CARA) presents at JP Morgan Healthcare Conference

Cara reports positive results of clinical trial for uremic pruritus candidate

Cara Therapeutics' lead candidate, I.V.  -More- 

Cara Therapeutics to Present at the 17th Annual Conference on Pain Therapeutics

Dr. Joseph Stauffer to deliver opening remarks and discuss kappa opioid receptor agonists as a novel approach to acute and chronic pain managementDr. Stauffer serves as co-chair and on the event’...

Cara Therapeutics nets $75.3mm in FOPO

Cara Therapeutics Inc. (peripheral nervous system-targeted drug development) netted $75.3mm through a follow-on offering of 4.45mm shares at $18. The company will use the proceeds to continue R&D acti...

PubMed Articles [564 Associated PubMed Articles listed on BioPortfolio]

Effect of pasteurization on flavonoids and carotenoids in Citrus sinensis (L.) Osbeck cv. «Cara Cara» and «Bahia» juices.

Orange juice is considered an excellent dietary source of several bioactive compounds with beneficial properties for human health. Citrus sinensis Osbeck cv. "Cara Cara" is a bud mutation originated f...

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria.

There is an urgent need to discover and progress anti-infectives that shorten the duration of tuberculosis (TB) treatment. Mycobacterium tuberculosis, the etiological agent of TB, is refractory to rap...

Lesión cribiforme en la cara de un varón de 44 años de edad.

El acantoma de la vaina pilosa es un tumor benignode piel muy poco frecuente. Suele presentarse comouna pápula asintomática, con un orificio central y lalocalización más frecuente es la cara. Pres...

Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:606-622.

Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:355-364.

Clinical Trials [110 Associated Clinical Trials listed on BioPortfolio]

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric cont...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1117 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.

CARA THERAPEUTICS -- OU NAME

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record